Reported 12 months ago
On June 27, 2024, a news article on Good Doctor News reported the successful treatment of a 14-year-old boy, referred to as C, suffering from severe atopic dermatitis. After struggling with various treatments and experiencing a significant improvement with the use of biologic agent Dupixent, funded by health insurance, C's condition visibly improved. Dr. Hsu stated that atopic dermatitis, a common chronic allergic skin disease in Taiwan, is now being effectively treated with biologic agents, offering more treatment options for patients and doctors. It's crucial to consult with a professional to ensure safe and effective disease control.
Source: YAHOO